Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06072924 · ClinicalTrials.gov registry record · NA

K01 Impacts of Lingual Endurance Exercise

A NA study of Stroke and Ischemic Stroke, sponsored by University of Cincinnati.

Recruiting
Registry status
NA
Development phase
70
Enrollment target
1
Study location

NCT06072924: Recruiting NA study of Stroke and Ischemic Stroke, sponsored by University of Cincinnati.

NCT06072924 is a NA study of Stroke and Ischemic Stroke that is actively recruiting participants, run by University of Cincinnati. The registered enrollment target is 70 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06072924, a NA study of Stroke and Ischemic Stroke, is actively recruiting participants, sponsored by University of Cincinnati.

RECRUITING
Registry status
NA
Development phase
70 participants
Enrollment target
1
Study location

Study Summary

The goal of this clinical trial is to learn whether a tongue endurance exercise program can improve swallowing function in adults with dysphagia after a stroke. It also aims to explore how this exercise may affect brain structure and connectivity involved in swallowing. The main questions it aims to answer are: Primary Aim: Does lingual endurance exercise improve swallowing function compared to a sham therapy? Secondary Aim: Does lingual endurance exercise lead to changes in brain structure or neuroplasticity, as measured by MRI? Researchers will compare a group receiving tongue endurance exercises to a sham therapy group to see whether the treatment improves tongue function, swallowing. Participants will: * Complete a baseline swallowing assessment and MRI * Be randomly assigned to either the lingual exercise or sham therapy group * Complete 8 weeks of home-based tongue exercise therapy * Return for follow-up swallowing assessments * A subgroup of participants will complete a pre-treatment and post-treatment MRI.

Primary Outcome

MBSImP is a validated, standardized tool for assessing oral, pharyngeal, and esophageal swallowing function. We will be using change in OT score (sum of components 1-6) as our primary outcome measure.

Interventions

  • BEHAVIORAL Isotonic Endurance Exercise
  • BEHAVIORAL Sham Exercise

Study Locations (1)

Ohio

  • University of Cincinnati - Cincinnati

Trial Details

FieldValue
Enrollment Target 70 participants
Start Date 2023-09-01
Est. Completion 2028-08-31
Phase NA
University of Cincinnati

245 total trials

What NCT06072924 shows while recruiting

NCT06072924 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 70 participants, a relatively small participant target, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (99% lower).

The record links to 4 conditions, with Stroke appearing as the primary indexed condition, and to 2 interventions - of which Isotonic Endurance Exercise is the first listed.

NCT06072924 reports a single indexed study location in Ohio.

Frequently Asked Questions

What is clinical trial NCT06072924 about?

NCT06072924 is a clinical study titled "K01 Impacts of Lingual Endurance Exercise". The goal of this clinical trial is to learn whether a tongue endurance exercise program can improve swallowing function in adults with dysphagia after a stroke. It also aims to explore how this exercise may affect brain structure and connectivity involved in swallowing. The main questions it aims to...

What is the current status of trial NCT06072924?

This trial is currently recruiting. It is a NA study. The enrollment target is 70 participants. The study started on 2023-09-01. Estimated completion is 2028-08-31.

What conditions does trial NCT06072924 study?

This clinical trial studies the following conditions: Stroke, Ischemic Stroke, Dysphagia, Dysphagia, Oropharyngeal.

What interventions are being tested in trial NCT06072924?

The interventions under investigation include: Isotonic Endurance Exercise (BEHAVIORAL), Sham Exercise (BEHAVIORAL).

Who is sponsoring clinical trial NCT06072924?

This trial is sponsored by University of Cincinnati, which has 245 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06072924 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06072924's enrollment target sits among peer trials

70 184th of 454 higher than 265 of 454 other Stroke trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Stroke trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00969111 · 70 participants · NA

    Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy

  • NCT01712620 · 70 participants · Phase 2

    Spironolactone for Pulmonary Arterial Hypertension

  • NCT02143830 · 70 participants · Phase 2

    HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy

  • NCT02601339 · 70 participants

    NIRS Monitoring in Premature Infants

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06072924, the US trial registry maintained by the National Library of Medicine. NCT06072924 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.